Kevin O'brien
About Kevin O'brien
Kevin O'Brien serves as the Chief Financial Officer at TetraGenetics Inc., bringing extensive experience in Department of Defense contracting and financial operations. He has a proven track record of managing significant company growth and has held various leadership roles in finance across multiple organizations.
Current Role at TetraGenetics Inc.
Kevin O'Brien serves as the Chief Financial Officer at TetraGenetics Inc. since 2019. In this role, he oversees the financial operations and strategic financial planning of the company. His responsibilities include managing financial risks, financial reporting, and ensuring compliance with regulatory requirements. TetraGenetics is focused on advancing the field of biotechnology, and O'Brien's expertise in finance plays a crucial role in supporting the company's growth and operational efficiency.
Previous Experience at PTC Therapeutics, Inc.
Before joining TetraGenetics, Kevin O'Brien worked at PTC Therapeutics, Inc. as Head of Finance Operations from 2018 to 2019. His tenure lasted for seven months and was based in Lynnfield, Massachusetts. In this position, he was responsible for overseeing financial operations and contributing to the company's financial strategy during a critical period of development.
Background in Finance and Operations
Kevin O'Brien has a diverse background in finance and operations across various companies. He served as Consulting CFO at Evolv Technology from 2013 to 2017 and held the position of Senior Director at Thermo Fisher Scientific from 2011 to 2013. His experience also includes being CFO and Vice President of Operations at OuterLink Corporation from 2003 to 2006. O'Brien's roles have equipped him with a strong understanding of financial management and operational strategy.
Education and Expertise
Kevin O'Brien holds a Master of Business Administration (M.B.A.) from Bentley University, where he studied Computer Information Systems from 1981 to 1984. He also earned a Bachelor of Science (BS) in Accounting from Northeastern University, studying from 1974 to 1979. His educational background provides a solid foundation for his extensive experience in finance, particularly in Department of Defense contracting and international sales contracts.
Achievements in Financial Growth
Throughout his career, Kevin O'Brien has demonstrated a strong ability to manage financial growth. Notably, he managed the growth of Ahura Scientific from $1 million to $80 million between 2006 and 2011, culminating in its acquisition by Thermo Fisher Scientific for $170 million. He also played a key role in rebuilding finance and IT at Innoveda Inc., facilitating its growth from $50 million in revenues to over $100 million within one year.